Literature DB >> 9711183

Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation.

G Finucci1, F Lunardi, D Sacerdoti, R Volpin, A Bortoluzzi, G Bombonato, P Angeli, A Gatta.   

Abstract

The aim of this work was to study the prevalence of Q-T prolongation in patients with liver cirrhosis and the modifications of the Q-T interval after liver transplantation. Q-T interval corrected for heart rate (QTc) and dispersion of Q-T interval were evaluated in 75 cirrhotic patients and in 24 controls by means of a 12-lead electrocardiogram. In addition, 15 patients were evaluated before and after liver transplantation. Forty-five patients (60%) had a prolonged Q-Tc. Compared with controls, both patients with alcoholic and non alcoholic cirrhosis had increased Q-Tc (414 +/- 28 msec1/2, 463 +/- 31 and 444 +/- 32 respectively; p < 0.001 and < 0.001); Q-Tc was significantly higher in alcoholic than in non-alcoholic cirrhosis (p < 0.02). Q-T dispersion was normal in cirrhotics. No correlation was found between Q-Tc interval and severity of the cirrhosis, haemodynamic variables (stroke volume, cardiac output) and s-calcium and potassium concentrations. After transplantation, Q-Tc decreased significantly (415 +/- 26 msec1/2 vs 449 +/- 31; p < 0.0001) returning to the values of the normal subjects, but no modification of the Q-T dispersion was observed. These data show that 1) prolongation of Q-T interval is frequent in cirrhosis, being higher in alcoholic than in non-alcoholic cirrhosis, 2) is not related to the severity of the disease, and 3) is reversible after transplantation.

Entities:  

Mesh:

Year:  1998        PMID: 9711183     DOI: 10.1536/ihj.39.321

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  13 in total

1.  Cardiac changes in pediatric liver transplant recipients: are they truly irreversible?

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2016-02-16       Impact factor: 6.047

2.  QT interval prolongation in end-stage liver disease cannot be explained by nonhepatic factors.

Authors:  Divyang Patel; Prabhpreet Singh; William Katz; Christopher Hughes; Kapil Chopra; Jan Němec
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-24       Impact factor: 1.468

3.  Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis.

Authors:  Moreshwar S Desai; Zeena Eblimit; Sundararajah Thevananther; Astrid Kosters; David D Moore; Daniel J Penny; Saul J Karpen
Journal:  Liver Int       Date:  2014-01-12       Impact factor: 5.828

4.  Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation.

Authors:  Moreshwar S Desai; Shabier Zainuer; Curtis Kennedy; Debra Kearney; John Goss; Saul J Karpen
Journal:  Gastroenterology       Date:  2011-07-14       Impact factor: 22.682

Review 5.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

6.  Alterations in corrected QT interval following liver transplant in patients with end-stage liver disease.

Authors:  Andrew O Zurick; Bret J Spier; Thomas C Teelin; Katelin R Lorenze; Cesar Alberte; Steven Zacks; Mary J Lindstrom; Patrick R Pfau; Kimberly Selzman
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

7.  Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease.

Authors:  Elizabeth J Carey; David D Douglas
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

8.  Echocardiographic and Electrocardiographic Predictors of Adverse Outcomes in Spontaneous Bacterial Peritonitis.

Authors:  Mahek Shah; Soumya Patnaik; Obiora Maludum; Shantanu Patil; Toni Anne De Venecia; Vincent M Figueredo
Journal:  J Clin Exp Hepatol       Date:  2017-05-15

9.  The Relationship between QT Interval Dispersion and End-Stage Liver Disease Score in the Patients Undergoing Orthotopic Liver Transplantation.

Authors:  Moghgan Zahmatkeshan; Ebrahim Fallahzadeh; Seyedeh Sadat Najib; Hamid Amoozgar; Seyed Ali Malekhosseini; Saman Nikeghbalian
Journal:  Int Cardiovasc Res J       Date:  2013-12-01

10.  Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis.

Authors:  Axel Josefsson; Michael Fu; Einar Björnsson; Evangelos Kalaitzakis
Journal:  BMC Gastroenterol       Date:  2014-04-05       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.